52/100BDR Horton financials
Yes. DR Horton earned 2.89B USD of net income over the last twelve months, 8.7% of its revenue. It made a profit in 32 of its 35 fiscal years since 1992. Its last loss was in fiscal year 2009.
- Revenue (TTM)
- 33.04B USD
- Net income (TTM)
- 2.89B USD
- Free cash flow (TTM)
- 3.35B USD
- Cash and short-term investments
- 2.06B USD
- Total debt
- 6.05B USD
- Shareholders' equity
- 23.11B USD
Cash, debt and equity as of 30 Sept 2026.
DR Horton earnings
Revenue
EPS
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|---|
| Q4 FY2027 | 2.87 | — | — | +7.67% | 9.06B | — | — | -3.28% | |
| Q3 FY2027 | 2.70 | — | — | -15.74% | 8.69B | — | — | -5.81% | |
| Q2 FY2027 | 1.86 | — | — | -17.00% | 7.26B | — | — | -3.97% | |
| Q1 FY2027 | 1.34 | — | — | -33.99% | 6.07B | — | — | -11.84% | |
| Q4 FY2026 | 3.01 | 2.67 | -11.30% | -12.17% | 9.07B | 9.37B | +3.32% | -3.17% | |
| Q3 FY2026 | 3.02 | 3.20 | +5.96% | -4.76% | 9.10B | 9.23B | +1.44% | +0.02% | |
| Q2 FY2026 | 2.15 | 2.24 | +4.19% | -13.18% | 7.55B | 7.56B | +0.11% | -2.27% | |
| Q1 FY2026 | 1.93 | 2.03 | +5.18% | -22.22% | 6.59B | 6.89B | +4.56% | -9.54% | |
| Q4 FY2025 | 3.27 | 3.04 | -7.03% | -22.45% | 9.41B | 9.68B | +2.81% | -3.25% | |
| Q3 FY2025 | 2.94 | 3.36 | +14.29% | -18.05% | 8.77B | 9.23B | +5.14% | -7.43% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2029 | 11.98 | — | — | +14.19% | 33.84B | — | — | +3.64% |
| FY2028 | 10.49 | — | — | +22.41% | 32.65B | — | — | +5.04% |
| FY2027 | 8.57 | — | — | -15.48% | 31.09B | — | — | -5.93% |
| FY2026 | 10.44 | 10.14 | -2.91% | -12.51% | 32.74B | 33.04B | +0.92% | -3.52% |
| FY2025 | 11.82 | 11.59 | -1.91% | -19.29% | 34.02B | 34.25B | +0.68% | -6.93% |
| FY2024 | 13.33 | 14.36 | +7.71% | +3.76% | 35.32B | 36.80B | +4.21% | +3.78% |
| FY2023 | 13.33 | 13.84 | +3.84% | -16.32% | 34.95B | 35.46B | +1.46% | +5.92% |
DR Horton growth and profitability
Full income statement- Revenue (TTM)
- 33.04B USD
- Net income (TTM)
- 2.89B USD
- Gross margin
- 22.28%
- Operating margin
- 11.41%
- Net margin
- 8.74%
Revenue / Net income
How DR Horton makes its money
FY2026, in USD. Each band is as wide as its money; the percentage is its share of revenue.
FY2026, in USD. Each band is as wide as its money; the percentage is its share of revenue.
DR Horton revenue breakdown
By product
| Segment | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Homebuilding | 31.52B | 91.9% | -7.2% |
| Forestar Group | 1.66B | 4.8% | +10.1% |
| Rental | 1.64B | 4.8% | -2.7% |
| Financial Services | 841.20M | 2.5% | -4.7% |
| Eliminations and Other | -1.36B | -4.0% | — |
By region
| Region | Revenue | Share of revenue | Change on the year |
|---|---|---|---|
| Southeast | 6.97B | 22.1% | -21.5% |
| South Central | 6.90B | 21.9% | -9.8% |
| East | 6.14B | 19.5% | +1.1% |
| Southwest | 4.60B | 14.6% | -6.5% |
| North | 4.23B | 13.4% | +14.7% |
| Northwest | 2.69B | 8.5% | -2.7% |
Operating and free cash flow
Full cash flow statementDR Horton financial health
Full balance sheet- Cash and short-term investments
- 2.06B USD
- Total debt
- 6.05B USD
- Net cash
- -3.99B USD
- Current ratio
- 6.01
- Debt to equity
- 0.26
- Piotroski score
- 5 / 9
- Altman Z-score
- 5.82
Cash, debt and free cash flow
Assets, liabilities and equity
DR Horton valuation
- Price to earnings ratio (TTM)
- 15.02
- Forward P/E (FY2027)
- 17.77
- Price to sales (TTM)
- 1.25
- Price to book
- 1.79
- EV / EBITDA (TTM)
- 11.56
Capital structure
Valuation over time
DR Horton against its own history
Each figure in the latest fiscal year against the same figure from FY2022 to FY2026: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.
Its peers: PulteGroup, Lennar, NVR, Toll Brothers, Installed Building Products, and Champion Homes, the US Residential Construction companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.
- P/E (today)Above its median15.04.315.6
- Gross marginLowest in 5 years22.3%22.3%31.4%Against its peers: 6 of 7Peers' median 26.2%
- Operating marginLowest in 5 years10.9%10.9%23.0%Against its peers: 5 of 7Peers' median 14.3%
- Net marginLowest in 5 years8.7%8.7%17.5%Against its peers: 5 of 7Peers' median 10.6%
- Return on equityLowest in 5 years12.5%12.5%30.2%Against its peers: 6 of 7Peers' median 16.7%
- Free cash flow marginAbove its median10.1%1.2%11.7%Against its peers: 2 of 7Peers' median 10.1%
- Revenue growthBelow its median-3.5%-6.9%20.5%Against its peers: 5 of 7Peers' median -0.5%
- EPS growthAt its median-12.6%-19.3%44.6%Against its peers: 4 of 7Peers' median -12.0%
- Debt to EBITDAHighest in 5 years1.50×0.79×1.50×Against its peers: 4 of 7Peers' median 1.18×
- Current ratioHighest in 5 years26.6913.1326.69Against its peers: 1 of 7Peers' median 3.54
Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.
DR Horton dividends
- Annual dividend
- 2.00 USD
- Dividend yield (indicated)
- 1.31%
- Payout ratio
- 22.68%
- Years of dividend growth
- 12
- Frequency
- Quarterly
- Last payment
- 0.50 USD
- Last ex-dividend date
- 12 Nov 2026
- Last payment date
- 19 Nov 2026
Dividends per share
DR Horton ownership
- Institutions
- 84.95%
- Institutional holders
- 1,296 (+87)
- Free float
- 89.58%
Who owns the shares
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Insider trading
| Quarter | Purchases | Sales | Shares acquired | Shares disposed of |
|---|---|---|---|---|
| Q3 2026 | 0 | 0 | 792.00 | 5.79K |
| Q2 2026 | 0 | 0 | 38.57K | 37.35K |
| Q1 2026 | 0 | 1 | 20.44K | 35.39K |
| Q4 2025 | 0 | 0 | 533.32K | 625.97K |
Shares outstanding
Common questions about DR Horton's financials
Source: Financial Modeling Prep